The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Patents, Royalties, Other Intellectual Property - Detection of LC3 (Inst)
Phase I trial of chloroquine (CQ)/hydroxychloroquine (HCQ) in combination with carboplatin-gemcitabine (CG) in patients with advanced solid tumors.
 
Nagla Fawzy Abdel Karim
Stock and Other Ownership Interests - Abbott Biotherapeutics (I)
Consulting or Advisory Role - Alexion Pharmaceuticals; Bayer; Immunocore
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Celgene; Genentech; Merck; Novartis; Pfizer
Research Funding - Pfizer
Expert Testimony - Exosome Diagnostics
 
Imran Ahmad
No Relationships to Disclose
 
Ola Gaber
No Relationships to Disclose
 
Ihab Eldessouki
Patents, Royalties, Other Intellectual Property - Detecton of LC3 (Inst)
 
Olugbenga Olanrele Olowokure
Speakers' Bureau - Bayer; Celgene
 
Maria Farooq
No Relationships to Disclose
 
John Charles Morris
Speakers' Bureau - Boehringer Ingelheim; Merck
Patents, Royalties, Other Intellectual Property - National Institutes of Health patent